EDITEditas Medicine, Inc.
What is the market doing?
No clear lean: nothing decisive, though a crowded short (+24% of shares).
Rangebound, no clear trend. Price is −10% vs its 200-day average.
A crowded short, settled Sep 30, 2026, more than a week of normal trading to cover, a crowded exit.
Where this answer is blind. Insider selling is often routine (taxes, diversification); only cluster buying is a strong tell.
How EDIT is trading
Editas Medicine, Inc. is −33% over the past year while the S&P 500 is +16%: 49 points behind the market.
1-year return · S&P 500 +16%
- vs 200-day average
- −10%
vs 200-day average · a clear downtrend
- RSI (14)
- 37
RSI (14) · neutral
- Below its 52-week high
- 36%
Below its 52-week high
Details›
- Last close2026-10-23
- $2.39
- 1 monthS&P 500 −0.94%
- −13%
- 1 yearS&P 500 +16%
- −33%
- 5 yearsS&P 500 +86%
- −94%
- vs 50-day average$2.78
- −14%
- 52-week high
- $3.74
- 52-week low
- $1.66
- Annualised volatility
- 114%
| Year | Return |
|---|---|
| 2026 (year to date) | +17% |
| 2025 | +61% |
| 2024 | −87% |
| 2023 | +14% |
| 2022 | −67% |
| 2021 | −62% |
| 2020 | +137% |
| 2019 | +30% |
| 2018 | −26% |
| 2017 | +89% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 10 | 4 of 10 | −4.9% |
| Feb | 10 | 5 of 10 | +7.5% |
| Mar | 10 | 3 of 10 | −7.9% |
| Apr | 10 | 5 of 10 | +0.12% |
| May | 10 | 5 of 10 | +0.43% |
| Jun | 10 | 6 of 10 | +12% |
| Jul | 11 | 7 of 11 | +1.4% |
| Aug | 11 | 7 of 11 | +5.0% |
| Sep | 11 | 2 of 11 | −8.4% |
| Oct | 11 | 4 of 11 | −6.0% |
| Nov | 10 | 5 of 10 | +7.1% |
| Dec | 10 | 3 of 10 | +2.3% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.
Where the price stands
Its trend against the 50-day and 200-day averages, and the levels it keeps coming back to.
What it has returned
With dividends, year by year, month by month, and by calendar month on average.